The result revealed a negative correlation between DLAT expression and the immune score across 27 different cancer types, including ACC, BRCA, CESC, ESCA, glioblastoma multiforme (GBM), GBMLGG, HNSC, LAML, LGG, LUAD, LUSC, mesothelioma (MESO), KIPAN, KIRC, KIRP, PCPG, PRAD, SARC, SKCM, metastatic skin cutaneous melanoma (SKCM-M), SKCM-P, STAD, STES, TGCT, THCA, thymoma (THYM), and uterine corpus endometrial carcinoma (UCEC). This evidence concerns the gene DLAT and adrenal cortex carcinoma.